{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:56:13Z","timestamp":1789754173301,"version":"4.0.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1124\/mol.114.096313","type":"journal-article","created":{"date-parts":[[2015,1,10]],"date-time":"2015-01-10T03:52:05Z","timestamp":1420861925000},"page":"582-594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Repression of the Nuclear Receptor Small Heterodimer Partner by Steatotic Drugs and in Advanced Nonalcoholic Fatty Liver Disease"],"prefix":"10.1016","volume":"87","author":[{"given":"Marta","family":"Benet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Pisonero-Vaquero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Victoria","family":"Garc\u00eda-Mediavilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"S\u00e1nchez-Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Luz","family":"Mart\u00ednez-Chantar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Teresa","family":"Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Vicente","family":"Castell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"Jover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.114.096313_bib1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.clnu.2009.08.014","article-title":"Inhibition of JNK along with activation of ERK1\/2 MAPK pathways improve steatohepatitis among the rats","volume":"29","author":"Aghazadeh","year":"2010","journal-title":"Clin Nutr"},{"key":"10.1124\/mol.114.096313_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0959-9673.2006.00465.x","article-title":"Mouse models in non-alcoholic fatty liver disease and steatohepatitis research","volume":"87","author":"Anstee","year":"2006","journal-title":"Int J Exp Pathol"},{"key":"10.1124\/mol.114.096313_bib3","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.tem.2005.10.005","article-title":"Transcriptional corepression by SHP: molecular mechanisms and physiological consequences","volume":"16","author":"B\u00e5vner","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"10.1124\/mol.114.096313_bib4","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2010.11.006","article-title":"Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver","volume":"54","author":"Begriche","year":"2011","journal-title":"J Hepatol"},{"key":"10.1124\/mol.114.096313_bib5","doi-asserted-by":"crossref","first-page":"28457","DOI":"10.1074\/jbc.M110.118364","volume":"285","author":"Benet","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.114.096313_bib6","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00204-014-1197-7","article-title":"A simple transcriptomic signature able to predict drug-induced hepatic steatosis","volume":"88","author":"Benet","year":"2014","journal-title":"Arch Toxicol"},{"key":"10.1124\/mol.114.096313_bib7","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/sj.emboj.7600728","article-title":"Regulation of hepatic metabolic pathways by the orphan nuclear receptor SHP","volume":"24","author":"Boulias","year":"2005","journal-title":"EMBO J"},{"key":"10.1124\/mol.114.096313_bib8","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1194\/jlr.M005546","article-title":"Retinoic acid represses CYP7A1 expression in human hepatocytes and HepG2 cells by FXR\/RXR-dependent and independent mechanisms","volume":"51","author":"Cai","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1124\/mol.114.096313_bib9","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1002\/hep.24607","article-title":"Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice","volume":"54","author":"Cano","year":"2011","journal-title":"Hepatology"},{"key":"10.1124\/mol.114.096313_bib10","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/hep.23049","article-title":"Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate-activated protein kinase-dependent induction of orphan nuclear receptor small heterodimer partner","volume":"50","author":"Chanda","year":"2009","journal-title":"Hepatology"},{"key":"10.1124\/mol.114.096313_bib11","doi-asserted-by":"crossref","first-page":"G349","DOI":"10.1152\/ajpgi.00417.2002","article-title":"Bile acid regulation of hepatic physiology: III. Bile acids and nuclear receptors","volume":"284","author":"Chiang","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/mol.114.096313_bib12","doi-asserted-by":"crossref","first-page":"946","DOI":"10.2174\/1389200211314090002","article-title":"Hepatic cell lines for drug hepatotoxicity testing: limitations and strategies to upgrade their metabolic competence by gene engineering","volume":"14","author":"Donato","year":"2013","journal-title":"Curr Drug Metab"},{"key":"10.1124\/mol.114.096313_bib13","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/1087057111427586","article-title":"High-content imaging technology for the evaluation of drug-induced steatosis using a multiparametric cell-based assay","volume":"17","author":"Donato","year":"2012","journal-title":"J Biomol Screen"},{"key":"10.1124\/mol.114.096313_bib14","doi-asserted-by":"crossref","first-page":"G1070","DOI":"10.1152\/ajpgi.00228.2004","article-title":"Oxidative DNA damage and DNA repair enzyme expression are inversely related in murine models of fatty liver disease","volume":"287","author":"Gao","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/mol.114.096313_bib15","doi-asserted-by":"crossref","first-page":"304292","DOI":"10.1155\/2012\/304292","article-title":"A pleiotropic role for the orphan nuclear receptor small heterodimer partner in lipid homeostasis and metabolic pathways","volume":"2012","author":"Garruti","year":"2012","journal-title":"J Lipids"},{"key":"10.1124\/mol.114.096313_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF02624157","article-title":"Culture of human hepatocytes from small surgical liver biopsies. Biochemical characterization and comparison with in vivo","volume":"26","author":"G\u00f3mez-Lech\u00f3n","year":"1990","journal-title":"In Vitro Cell Dev Biol"},{"key":"10.1124\/mol.114.096313_bib17","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/(SICI)1097-4652(199812)177:4<553::AID-JCP6>3.0.CO;2-F","article-title":"Long-term expression of differentiated functions in hepatocytes cultured in three-dimensional collagen matrix","volume":"177","author":"G\u00f3mez-Lech\u00f3n","year":"1998","journal-title":"J Cell Physiol"},{"key":"10.1124\/mol.114.096313_bib18","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.bbalip.2012.12.014","article-title":"The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPAR\u03b1; and repressed by C\/EBP\u03b1: Implications in FABP1 down-regulation in nonalcoholic fatty liver disease","volume":"1831","author":"Guzm\u00e1n","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/mol.114.096313_bib19","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1124\/dmd.109.031831","article-title":"A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues","volume":"38","author":"Hart","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.114.096313_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1194\/jlr.M800323-JLR200","article-title":"Loss of small heterodimer partner expression in the liver protects against dyslipidemia","volume":"50","author":"Hartman","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1124\/mol.114.096313_bib21","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1053\/j.gastro.2008.01.006","article-title":"Epigenetic inhibition of nuclear receptor small heterodimer partner is associated with and regulates hepatocellular carcinoma growth","volume":"134","author":"He","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1124\/mol.114.096313_bib22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1021\/mp800131d","article-title":"Activation of the nuclear receptor PXR decreases plasma LDL-cholesterol levels and induces hepatic steatosis in LDL receptor knockout mice","volume":"6","author":"Hoekstra","year":"2009","journal-title":"Mol Pharm"},{"key":"10.1124\/mol.114.096313_bib23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/hep.21632","article-title":"Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver","volume":"46","author":"Huang","year":"2007","journal-title":"Hepatology"},{"key":"10.1124\/mol.114.096313_bib24","doi-asserted-by":"crossref","first-page":"21833","DOI":"10.3390\/ijms141121833","article-title":"Rodent models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"14","author":"Imajo","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1124\/mol.114.096313_bib25","first-page":"2683","article-title":"Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL\/6 mice","volume":"6","author":"Itagaki","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1124\/mol.114.096313_bib26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0014-5793(98)00746-7","article-title":"Re-expression of C\/EBP alpha induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells","volume":"431","author":"Jover","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1124\/mol.114.096313_bib27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bbrc.2007.05.171","article-title":"Transcriptional activation of SHP by PPAR-gamma in liver","volume":"360","author":"Kim","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/mol.114.096313_bib28","doi-asserted-by":"crossref","first-page":"21327","DOI":"10.1074\/jbc.M701759200","article-title":"Mitochondrial reactive oxygen species signal hepatocyte steatosis by regulating the phosphatidylinositol 3-kinase cell survival pathway","volume":"282","author":"Kohli","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.114.096313_bib29","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.bcp.2011.08.023","article-title":"Metformin suppresses pregnane X receptor (PXR)-regulated transactivation of CYP3A4 gene","volume":"82","author":"Krausova","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.114.096313_bib30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.cld.2012.05.009","article-title":"A myriad of pathways to NASH","volume":"16","author":"Larrain","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1124\/mol.114.096313_bib31","doi-asserted-by":"crossref","first-page":"14398","DOI":"10.1074\/jbc.273.23.14398","article-title":"Structure and expression of the orphan nuclear receptor SHP gene","volume":"273","author":"Lee","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.114.096313_bib32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1021\/mp700121u","article-title":"PXR and LXR in hepatic steatosis: a new dog and an old dog with new tricks","volume":"5","author":"Lee","year":"2008","journal-title":"Mol Pharm"},{"key":"10.1124\/mol.114.096313_bib33","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1124\/dmd.105.007575","article-title":"Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4alpha and coactivators, and suppression of small heterodimer partner gene expression","volume":"34","author":"Li","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.114.096313_bib34","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.1073\/pnas.091016398","article-title":"Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation","volume":"98","author":"Lu","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.114.096313_bib35","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1096\/fj.02-0078fje","article-title":"Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A","volume":"16","author":"Mart\u00ednez-Chantar","year":"2002","journal-title":"FASEB J"},{"key":"10.1124\/mol.114.096313_bib36","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/hep.22159","article-title":"Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice","volume":"47","author":"Mart\u00ednez-Chantar","year":"2008","journal-title":"Hepatology"},{"key":"10.1124\/mol.114.096313_bib37","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1073\/pnas.90.6.2207","article-title":"Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6","volume":"90","author":"Nakajima","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.114.096313_bib38","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ceb.2008.02.002","article-title":"C\/EBPs: recipients of extracellular signals through proteome modulation","volume":"20","author":"Nerlov","year":"2008","journal-title":"Curr Opin Cell Biol"},{"key":"10.1124\/mol.114.096313_bib39","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s00204-006-0091-3","article-title":"High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening","volume":"80","author":"O\u2019Brien","year":"2006","journal-title":"Arch Toxicol"},{"key":"10.1124\/mol.114.096313_bib40","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/hep.22196","article-title":"Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis","volume":"47","author":"Park","year":"2008","journal-title":"Hepatology"},{"key":"10.1124\/mol.114.096313_bib41","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/sj.emboj.7601563","article-title":"Distinct C\/EBPalpha motifs regulate lipogenic and gluconeogenic gene expression in vivo","volume":"26","author":"Pedersen","year":"2007","journal-title":"EMBO J"},{"key":"10.1124\/mol.114.096313_bib42","doi-asserted-by":"crossref","first-page":"24390","DOI":"10.1074\/jbc.M603038200","article-title":"CCAAT\/enhancer-binding protein alpha mediates induction of hepatic phosphoenolpyruvate carboxykinase by p38 mitogen-activated protein kinase","volume":"281","author":"Qiao","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.114.096313_bib43","doi-asserted-by":"crossref","first-page":"8433","DOI":"10.1128\/MCB.19.12.8433","article-title":"Glycogen synthase kinase 3 is an insulin-regulated C\/EBPalpha kinase","volume":"19","author":"Ross","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.114.096313_bib44","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1128\/MCB.24.2.675-686.2004","article-title":"Phosphorylation of C\/EBPalpha inhibits granulopoiesis","volume":"24","author":"Ross","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.114.096313_bib45","doi-asserted-by":"crossref","first-page":"G55","DOI":"10.1152\/ajpgi.00360.2005","article-title":"Roles of phosphatidylinositol 3-kinase and osteopontin in steatosis and aminotransferase release by hepatocytes treated with methionine-choline-deficient medium","volume":"291","author":"Sahai","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/mol.114.096313_bib46","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1126\/science.272.5266.1336","article-title":"An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors","volume":"272","author":"Seol","year":"1996","journal-title":"Science"},{"key":"10.1124\/mol.114.096313_bib47","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.2337\/diabetes.50.11.2472","article-title":"Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism","volume":"50","author":"Shih","year":"2001","journal-title":"Diabetes"},{"key":"10.1124\/mol.114.096313_bib48","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3748\/wjg.v18.i19.2300","article-title":"Animal models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"18","author":"Takahashi","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1124\/mol.114.096313_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.21801","article-title":"A little orphan runs to fat: the orphan receptor small heterodimer partner as a key player in the regulation of hepatic lipid metabolism","volume":"46","author":"Trauner","year":"2007","journal-title":"Hepatology"},{"key":"10.1124\/mol.114.096313_bib50","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cyto.2010.12.019","article-title":"The CCAAT\/enhancer (C\/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation","volume":"54","author":"Tsukada","year":"2011","journal-title":"Cytokine"},{"key":"10.1124\/mol.114.096313_bib51","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2011.06.040","article-title":"Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis","volume":"141","author":"Van Rooyen","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1124\/mol.114.096313_bib52","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/hep.23639","article-title":"Fatty liver and fibrosis in glycine N-methyltransferase knockout mice is prevented by nicotinamide","volume":"52","author":"Varela-Rey","year":"2010","journal-title":"Hepatology"},{"key":"10.1124\/mol.114.096313_bib53","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1101\/gad.1183304","article-title":"Liver tumors escape negative control of proliferation via PI3K\/Akt-mediated block of C\/EBP alpha growth inhibitory activity","volume":"18","author":"Wang","year":"2004","journal-title":"Genes Dev"},{"key":"10.1124\/mol.114.096313_bib54","doi-asserted-by":"crossref","first-page":"44475","DOI":"10.1074\/jbc.M305258200","article-title":"Resistance of SHP-null mice to bile acid-induced liver damage","volume":"278","author":"Wang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.114.096313_bib55","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1258\/ebm.2010.010160","article-title":"Extracellular signal-regulated kinases 1\/2 suppression aggravates transforming growth factor-beta1 hepatotoxicity: a potential mechanism for liver injury in methionine-choline deficient-diet-fed mice","volume":"235","author":"Wang","year":"2010","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1124\/mol.114.096313_bib56","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1194\/jlr.M007948","article-title":"Involvement and mechanism of DGAT2 upregulation in the pathogenesis of alcoholic fatty liver disease","volume":"51","author":"Wang","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1124\/mol.114.096313_bib57","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.5754\/hge11005","article-title":"Impaired activation of phosphatidylinositol 3-kinase by leptin is a novel mechanism of hepatic leptin resistance in NAFLD","volume":"58","author":"Xu","year":"2011","journal-title":"Hepatogastroenterology"},{"key":"10.1124\/mol.114.096313_bib58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/toxsci\/kfn109","article-title":"Cellular imaging predictions of clinical drug-induced liver injury","volume":"105","author":"Xu","year":"2008","journal-title":"Toxicol Sci"},{"key":"10.1124\/mol.114.096313_bib59","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.bbadis.2010.10.006","article-title":"Role of nuclear receptor SHP in metabolism and cancer","volume":"1812","author":"Zhang","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/mol.114.096313_bib60","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1128\/MCB.01076-09","article-title":"Nuclear receptor SHP, a death receptor that targets mitochondria, induces apoptosis and inhibits tumor growth","volume":"30","author":"Zhang","year":"2010","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.114.096313_bib61","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/hep.27121","article-title":"E2F1 is a novel fibrogenic gene that regulates cholestatic liver fibrosis through the Egr-1\/SHP\/EID1 network","volume":"60","author":"Zhang","year":"2014","journal-title":"Hepatology"},{"key":"10.1124\/mol.114.096313_bib62","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.22342","article-title":"Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation","volume":"48","author":"Zhang","year":"2008","journal-title":"Hepatology"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24030499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24030499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.114.096313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:04:00Z","timestamp":1739959440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24030499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0026895X24030499"],"URL":"https:\/\/doi.org\/10.1124\/mol.114.096313","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repression of the Nuclear Receptor Small Heterodimer Partner by Steatotic Drugs and in Advanced Nonalcoholic Fatty Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.114.096313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}